A clinical trial designed to test repurposed medications for their impact on fighting COVID-19 has found no benefit to taking the antidepressant fluvoxamine (Luvox) to ease coronavirus symptoms.
The study, led by Duke Clinical Research Institute (DCRI) in partnership wit...
Certain commonly prescribed antidepressants appear to substantially lower the risk of dying among seriously ill COVID-19 patients, a large new study indicates.
Selective serotonin reuptake inhibitors (SSRIs) are among the most widely prescribed drugs for the treatment of...
The commonly used antidepressant Prozac doesn't appear to help reduce obsessive-compulsive behavior in children and teens with autism, new research suggests.
The study randomly compared use of the drug to a placebo over 16 weeks. In the end, the researchers saw no m...